 |
 |
Mr. Blum
is the Director of Portfolio Operations at Two
River. He is responsible for supporting drug
development activities at Two River portfolio
companies, including clinical operations,
manufacturing, preclinical studies and regulatory
affairs. Mr. Blum has worked to advance numerous
novel therapies through preclinical and clinical
development in oncology, ophthalmology and
cardiovascular disease.
Mr. Blum received his Master’s in Biotechnology from the University of
Pennsylvania. He also graduated magna cum laude with
a B.S. in Economics from the Wharton School and a
B.A.S. in Biomedical Science from the School of
Engineering at the University of Pennsylvania.
|
|
|
|
|
